Benzinga's M&A Chatter for Thursday April 16, 2015

The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday April 16, 2015:

:

CollabRx, Inc. (NASDAQ:

) and Medytox Solutions (OTC:

) announced Thursday, that they have entered into a definitive merger agreement. Under the agreement, CollabRx equityholders will own a 10% stake in the combined company and Medytox equityholders will own 90% of the combined company. CollabRx shares rose 9% Thursday, closing at $1.14.

:

The Macerich Company (NYSE:

) shareholder, Cohen & Steers Inc (NASDAQ:

) asked Macerich to come up with a plan to deliver the same value as was offered by Simon Property Group Inc (NYSE:

), when they offered $95.50 per share. Cohen & Steers' Executive Chairman Martin Cohen told

on Wednesday, that he favored Simon's offer, which was rejected by Macerich. A Macerich spokesman declined to comment on the Cohen comments. Macerich shareholders Land and Buildings and Orange Capital also expressed their dissatisfaction at the rejected Simon offer in a letter to Macerich Chairman and CEO Art Coppola. Macerich shares gained $0.69 Thursday, closing at $82.99.

:

Shares of Xilinx Inc. (NASDAQ:

) rose Thursday, on a

story that Intel Corporation (NASDAQ:

) might be leaning toward an acquisition of Xilinx, versus the previously rumored Altera Corp (NASDAQ:

). The

first reported on March 27, that Intel was in talks to acquire Altera. Those talks reportedly ended without an agreement, when Altera rejected a $54.00 per share offer, according to sources. Xilinx shares gained $0.43 Thursday, closing at $44.33. Alter shares lost $0.07, closing at $43.35.